◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

REVOLUTION MEDICINES, INC.

CIK: 1628171 SIC: 2836
-
Revenue
$-1.13B
Net Income
-
Gross Margin
-
Op. Margin
$-1.54B
Free Cash Flow
Financial Statements Quarterly (10-Q)
Showing 7 of 18 quarterly reports available
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
+ Total Revenue - - - - - - -
Revenue Growth % (YoY) nan% nan% nan% nan% nan% nan% nan%
Operating Expenses $361.63M $315.27M $264.71M $240.76M $216.31M $175.71M $156.64M
Research & Development $294.94M $262.51M $224.13M $205.75M $188.10M $151.75M $134.93M
+ Operating Income $-361.63M $-315.27M $-264.71M $-240.76M $-216.31M $-175.71M $-156.64M
Operating Margin % nan% nan% nan% nan% nan% nan% nan%
Interest Expense $11.94M $11.43M - - - - -
Interest Income $21.29M $22.08M $22.40M $24.91M $21.23M $20.41M $21.49M
Other Income/Expense $-3.27M - $16.93M $-10.00K $20.99M $282.00K $16.00K
Income Before Tax $-364.89M $-305.21M $-247.79M $-213.42M $-195.32M $-156.29M $-133.23M
Income Tax Expense - - - - $-753.00K - -
+ Net Income $-364.89M $-305.21M $-247.79M $-213.42M $-194.57M $-156.29M $-133.23M
Net Margin % nan% nan% nan% nan% nan% nan% nan%
Basic EPS nan -1.61 -1.31 -1.13 nan -0.94 -0.81
Diluted EPS nan -1.61 -1.31 -1.13 nan -0.94 -0.81
Basic Shares Outstanding - 189.2M 188.6M 188.1M - 166.8M 165.1M
Diluted Shares Outstanding - 189.2M 188.6M 188.1M - 166.8M 165.1M
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Cash & Cash Equivalents $383.75M $217.44M $402.44M $333.55M $543.06M $201.26M $275.71M
Short-term Investments $1.64B $1.71B $1.73B $1.77B $1.75B $1.35B $1.32B
Other Current Assets $49.36M $45.98M $39.27M $31.91M $38.33M $29.66M $34.02M
Total Current Assets $2.08B $1.98B $2.18B $2.13B $2.33B $1.58B $1.62B
Property Plant & Equipment $33.19M $32.93M $33.05M $27.15M $24.29M $24.81M $25.28M
Goodwill $14.61M $14.61M $14.61M $14.61M $14.61M $14.61M $14.61M
Intangible Assets $55.80M $55.87M $56.14M $56.40M $56.67M $56.94M $57.20M
Other Non-current Assets $14.78M $14.87M $31.42M $13.13M $13.87M $10.28M $8.27M
Total Assets $2.35B $2.25B $2.43B $2.37B $2.56B $1.76B $1.81B
Accounts Payable $64.62M $74.85M $56.76M $47.51M $54.43M $24.46M $29.32M
Accrued Liabilities $5.00M - - - - - -
Other Current Liabilities $7.86M - - - $583.00K - -
Total Current Liabilities $290.42M $245.62M $184.53M $158.60M $163.91M $110.86M $105.33M
Deferred Tax Liabilities $2.35M $2.35M $2.35M $2.35M $2.35M $3.12M $3.12M
Other Non-current Liabilities $1.21M $2.48M $7.20M $4.14M $670.00K $1.64M $656.00K
Total Liabilities $723.21M $655.02M $564.20M $287.20M $293.10M $196.69M $189.59M
Common Stock $19.00K $18.00K $18.00K $18.00K $18.00K $16.00K $16.00K
Retained Earnings $-2.87B $-2.50B $-2.20B $-1.95B $-1.74B $-1.54B $-1.39B
Total Stockholders Equity $1.63B $1.60B $1.87B $2.08B $2.27B $1.57B $1.62B
Total Liabilities & Equity $2.35B $2.25B $2.43B $2.37B $2.56B $1.76B $1.81B
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Net Income $-364.89M $-305.21M $-461.20M $-213.42M $-194.57M $-156.29M $-249.24M
Stock-based Compensation $33.70M $84.69M $53.91M $25.08M $22.44M $56.76M $35.98M
Change in Receivables - - - - - $-1.25M $-1.25M
Change in Payables $-10.50M $20.04M $491.00K $-8.27M $29.36M $-35.83M $-33.04M
Operating Cash Flow $-274.24M $-623.50M $-416.19M $-194.44M $-138.29M $-419.15M $-288.73M
Capital Expenditure $1.93M $14.06M $10.72M $3.27M $1.22M $9.09M $5.57M
Purchases of Investments $296.49M $1.50B $1.04B $510.04M $695.21M $1.44B $1.08B
Investing Cash Flow $74.88M $43.18M $18.33M $-15.95M $-392.90M $-161.49M $-140.02M
Stock Issued - - - - $727.62M - -
Financing Cash Flow $365.66M $255.87M $257.46M $874.00K $873.80M $85.61M $8.31M
Net Change in Cash $166.30M $-324.46M $-140.41M $-209.51M $342.61M $-495.03M $-420.44M
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Operating Expenses $315.27M - $820.74M -
Research & Development $262.51M - $692.39M -
Operating Income $-315.27M - $-820.74M -
Interest Expense $11.43M - $12.29M -
Interest Income $22.08M - $69.40M -
Other Income/Expense - - $-42.00K -
Income Before Tax $-305.21M - $-766.41M -
Net Income $-305.21M $-133.23M $-766.41M -
Basic EPS -1.61 - -4.06 -
Diluted EPS -1.61 - -4.06 -
Basic Shares Outstanding $189.23M - $188.66M -
Diluted Shares Outstanding $189.23M - $188.66M -
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $217.44M $543.06M
Short-term Investments $1.71B $1.75B
Other Current Assets $45.98M $38.33M
Total Current Assets $1.98B $2.33B
Property Plant & Equipment $32.93M $24.29M
Goodwill $14.61M $14.61M
Intangible Assets $55.87M $56.67M
Other Non-current Assets $14.87M $1.74M
Total Assets $2.25B $2.56B
Accounts Payable $74.85M $54.43M
Total Current Liabilities $245.62M $163.91M
Deferred Tax Liabilities $2.35M $2.35M
Other Non-current Liabilities $2.48M $670.00K
Total Liabilities $655.02M $293.10M
Common Stock $18.00K $18.00K
Retained Earnings $-2.50B $-1.74B
Total Stockholders Equity $1.60B $2.27B
Total Liabilities & Equity $2.25B $2.56B
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $-305.21M $-133.23M $-766.41M -
Stock-based Compensation - - $84.69M -
Change in Receivables - - - -
Change in Payables - - $20.04M -
Operating Cash Flow - - $-623.50M -
Capital Expenditure - - $14.06M -
Purchases of Investments - - $1.50B -
Investing Cash Flow - - $43.18M -
Financing Cash Flow - - $255.87M -
Net Change in Cash - - $-324.46M -

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.

Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...